Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 20 di 209
Titolo Data di pubblicazione Autore(i) File
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study 1-gen-1997 Bruno, S; Silini, Enrico Maria; Crosignani, A; Borzio, F; Leandro, G; Bono, F; Asti, M; Rossi, L; Larghi, A; Cerino, A; Podda, M; Mondelli, Mu
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects 1-gen-1997 Cerino, A; Bissolati, M; Cividini, A; Nicosia, A; Esumi, M; Slobbe, R; Silini, Enrico Maria; Asti, M; Mondelli, Mu
Hepatitis C virus genotypes and severe hepatitis C virus recurrence after liver transplantation 1-gen-1997 Alberti, Ab; Belli, Ls; Silini, Enrico Maria; Zavaglia, C; Iamoni, G; Rondinara, Gf; DE CARLIS, L; Forti, D; Ideo, G.
Both immunogenetic factors and HCV genotype can influence the outcome of chronic HCV infection 1-gen-1997 Zavaglia, C; Belli, Ls; Alberti, Ab; Ideo, G; Silini, Enrico Maria
Latent human papillomavirus infection in pregnant women at term: a case-control study 1-gen-1997 Tenti, P; Zappatore, R; Migliora, P; Spinillo, A; Maccarini, U; DE BENEDITTIS, M; Vesentini, N; Marchitelli, G; Silini, Enrico Maria; Carnevali, L.
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk 1-gen-1997 Cividini, A; Pistorio, A; Regazzetti, A; Cerino, A; Tinelli, C; Mancuso, A; Ribola, M; Galli, Ml; Agnusdei, A; Leone, M; Silini, Enrico Maria; Mondelli, Mu
Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial 1-gen-1997 Bellobuono, A; Mondazzi, L; Tempini, S; Silini, Enrico Maria; Vicari, F; Ideo, G.
Retreatment of chronic hepatitis C with ribavirin followed by α-interferon 1-gen-1997 Bellobuono, A; Mondazzi, L; Tempini, S; Silini, Enrico Maria; Vicari, F; Asti, L; Zavaglia, C; Ideo, G.
Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment 1-gen-1997 Bellobuono, A; Mondazzi, L; Tempini, S; Silini, Enrico Maria; Ideo, G.
HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection 1-gen-1998 Silini, Enrico Maria; Belli, L; Alberti, Ab; Asti, M; Cerino, A; Bissolati, M; Rondinara, G; Decarlis, L; Forti, D; Mondelli, Mu; Ideo, G.
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 1-gen-1998 DE FILIPPI, F; Castelli, R; Cicardi, M; Soffredini, R; Rumi, Mg; Silini, Enrico Maria; Mannucci, Pm; Colombo, M.
Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease 1-gen-1998 Brambilla, S; Bellati, G; Asti, M; Lisa, A; Candusso, Me; D'Amicom, ; Grassi, G; Giacca, M; Franchini, A; Bruno, S; Ideo, G; Mondelli, Mu; Silini, Enrico Maria
Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C 1-gen-1998 Zavaglia, C; Martinetti, M; Silini, Enrico Maria; Bottelli, R; Daielli, C; Asti, M; Airoldi, A; Salvaneschi, L; Mondelli, Mu; Ideo, G.
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 1-gen-1998 Maggiore, G; Caprai, S; Cerino, A; Silini, Enrico Maria; Mondelli, Mu
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease 1-gen-1999 Asti, M; Martinetti, M; Zavaglia, C; Cuccia, Mc; Gusberti, L; Tinelli, C; Cividini, A; Bruno, S; Salvaneschi, L; Ideo, G; Mondelli, Mu; Silini, Enrico Maria
Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study 1-gen-1999 Osella, A; Sonzogni, L; Cavallini, A; Foti, L; Guerra, V; DI LEO, A; Mondelli, Mu; Misciagna, G; Silini, Enrico Maria
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 1-gen-1999 Mondelli, Mu; Cerino, A; Lisa, A; Brambilla, S; Segagni, L; Cividini, A; Bissolati, M; Missale, G; Bellati, G; Meola, A; Bruniercole, B; Nicosia, A; Galfre, G; Silini, Enrico Maria
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 1-gen-1999 Mondelli, M. U.; Cerino, A.; Lisa, A.; Brambilla, S.; Segagni, L.; Cividini, A.; Bissolati, M.; Missale, G.; Bellati, G.; Meola, A.; Bruniercole, B.; Nicosia, A.; Galfre, G.; Silini, E.
GB virus type C infection in patients treated for childhood acute lymphoblastic leukemia 1-gen-1999 Aric, M; Bissolati, M; Bossi, G; Asti, M; Cerino, A; Caselli, D; Ricci, A; Klersy, C; Silini, Enrico Maria; Mondelli, Mu
Clinical significance of hepatitis C virus genotypes 1-gen-1999 Mondelli, Mu; Silini, Enrico Maria
Mostrati risultati da 1 a 20 di 209
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile